Lab Reagents
Human IgG antibody Laboratories manufactures the avian influenza virus antibody elisa kit reagents distributed by Genprice. The Avian Influenza Virus Antibody Elisa Kit reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact influenza Antibody. Other Avian products are available in stock. Specificity: Avian Category: Influenza Group: Virus Antibody
Virus Antibody information
Avian influenza virus, serotype H7 RT PCR kit |
RTq-V591-50R |
Bioingentech |
50T |
EUR 1155.6 |
Avian influenza virus, serotype H9 RT PCR kit |
RTq-V592-100R |
Bioingentech |
100T |
EUR 1573.2 |
Avian influenza virus, serotype H9 RT PCR kit |
RTq-V592-150R |
Bioingentech |
150T |
EUR 2144.4 |
Avian influenza virus, serotype H9 RT PCR kit |
RTq-V592-50R |
Bioingentech |
50T |
EUR 1155.6 |
Avian influenza virus, serotype H5 RT PCR kit |
RTq-V593-100R |
Bioingentech |
100T |
EUR 1573.2 |
Avian influenza virus, serotype H5 RT PCR kit |
RTq-V593-150R |
Bioingentech |
150T |
EUR 2144.4 |
Avian influenza virus, serotype H5 RT PCR kit |
RTq-V593-50R |
Bioingentech |
50T |
EUR 1155.6 |
Avian Influenza Neuraminidase Antibody |
24274-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Neuraminidase Antibody |
24275-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin Antibody |
24276-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin Antibody |
24277-100ul |
SAB |
100ul |
EUR 468 |
Avian Influenza Hemagglutinin Antibody |
3425-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
3425-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
3427-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Hemagglutinin Antibody |
3427-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Hemagglutinin Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species-jumping ability. |
Avian Influenza Neuraminidase Antibody |
3421-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |
Avian Influenza Neuraminidase Antibody |
3421-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: Avian Influenza Neuraminidase Antibody: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA. Novel influenza virus strains emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. Although it has been known that cleavage site and glycosylation patterns of the HA protein play important roles in determining the pathogenicity of H5 avian influenza viruses, it has only recently been shown that an additional glycosylation site within the globular head of the NA protein also contributes to the high virulence of the H5N1 virus. |